This site uses cookies to improve your experience and to provide services and advertising. By continuing to browse, you agree to the use of cookies described in our Cookies Policy. You may change your settings at any time but this may impact on the functionality of the site. To learn more see our Cookies Policy.
OK
Dublin: 10 °C Thursday 24 October, 2019
Advertisement

CAS to publish Contador ruling on Monday

The announcement comes 16 months after the three-time Tour de France winner tested positive for the steroid clenbuterol.

Image: Laurent Cipriani/AP/Press Association Images

THE COURT OF Arbitration for Sport has declared its intention to publish a final judgement in the case of Spanish cyclist Alberto Contador this coming Monday.

The three-time Tour de France winner tested positive for the steroid clenbuterol in September 2010. The Spaniard later claimed the result could be traced to contaminated beef, an excuse deemed satisfactory by the Spanish Cycling Federation (RFEC), who cleared the rider to compete during the 2011 season.

That decision was subsequently challenged by both the Union Cycliste Internationale (UCI) and the World Anti-Doping Agency (WADA), a move that spurred a protracted legal battle between the two sides.

Today’s announcement by the court suggests a resolution may finally be at hand:

“The Court of Arbitration for Sport (CAS) intends to publish its decision in the arbitration procedure involving the International Cycling Union (UCI), the World Anti-Doping Agency (WADA), Alberto Contador and the Spanish Cycling Federation (RFEC) on Monday 6 February 2012.

“A confirmation as to the date and time of the publication of the decision will be given by the CAS at the end of this week.”

If found guilty, Contador will likely be stripped of both the 2010 Tour de France and 2011 Giro d’Italia titles.

Andy O’Brien returns to Leeds following treatment for depression

Making a dfference: the other side of Craig Bellamy

Pack of eight: All you need to know about Scotland

  • Share on Facebook
  • Email this article
  •  

About the author:

Read next:

COMMENTS